A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion
(Q33417902)
scientific article
scientific article
Language:
Current Data About
A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion
other details
| description | scientific article |
External Links
| (P356) |
10.1007/BF00257627
|
| (P698) |
2526692
|
| (P6179) |
1015008964
|
| (P8608) |
release_q2ef23gb4nfxtcyc5hwbv6rb2u
|